Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin

Chenchen Bing, Pratik Patel, Robert M. Staruch, Sumbul Shaikh, Joris Nofiele, Michelle Wodzak Staruch, Debra Szczepanski, Noelle S. Williams, Theodore W Laetsch, Rajiv Chopra

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Thermosensitive liposomal doxorubicin (LTSL-Dox) combined with mild hyperthermia enhances the localized delivery of doxorubicin (Dox) within a heated region. The optimal heating duration and the impact of extended heating on systemic drug distribution are unknown. Here we evaluated local and systemic Dox delivery with two different mild hyperthermia durations (42 °C for 10 or 40 minutes) in a Vx2 rabbit tumor model. We hypothesized that longer duration of hyperthermia would increase Dox concentration in heated tumors without increasing systemic exposure. Temporally and spatially accurate controlled hyperthermia was achieved using a clinical MR-HIFU system for the prescribed heating durations. Forty-minutes of heating resulted in a nearly 6-fold increase in doxorubicin concentration in heated vs unheated tumors in the same animals. Therapeutic ratio, defined as the ratio of Dox delivered into the heated tumor vs the heart, increased from 1.9-fold with 10 minutes heating to 4.4-fold with 40 minutes heating. MR-HIFU can be used to guide, deliver and monitor mild hyperthermia of a Vx2 tumor model in a rabbit model, and an increased duration of heating leads to higher Dox deposition from LTSL-Dox in a target tumor without a concomitant increase in systemic exposure. Results from this preclinical study can be used to help establish clinical treatment protocols for hyperthermia mediated drug delivery.

Original languageEnglish (US)
JournalInternational Journal of Hyperthermia
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Doxorubicin
Heating
Fever
Neoplasms
Therapeutics
Clinical Protocols
Rabbits
Heart Neoplasms
liposomal doxorubicin
Pharmaceutical Preparations

Keywords

  • mild hyperthermia
  • MR-guided high intensity focused ultrasound
  • Targeted drug delivery
  • therapeutic ratio
  • thermosensitive liposomal doxorubicin

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cancer Research

Cite this

Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin. / Bing, Chenchen; Patel, Pratik; Staruch, Robert M.; Shaikh, Sumbul; Nofiele, Joris; Wodzak Staruch, Michelle; Szczepanski, Debra; Williams, Noelle S.; Laetsch, Theodore W; Chopra, Rajiv.

In: International Journal of Hyperthermia, 01.01.2018.

Research output: Contribution to journalArticle

Bing, Chenchen ; Patel, Pratik ; Staruch, Robert M. ; Shaikh, Sumbul ; Nofiele, Joris ; Wodzak Staruch, Michelle ; Szczepanski, Debra ; Williams, Noelle S. ; Laetsch, Theodore W ; Chopra, Rajiv. / Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin. In: International Journal of Hyperthermia. 2018.
@article{a1d8ce9935534eef85cfb9567b616efe,
title = "Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin",
abstract = "Thermosensitive liposomal doxorubicin (LTSL-Dox) combined with mild hyperthermia enhances the localized delivery of doxorubicin (Dox) within a heated region. The optimal heating duration and the impact of extended heating on systemic drug distribution are unknown. Here we evaluated local and systemic Dox delivery with two different mild hyperthermia durations (42 °C for 10 or 40 minutes) in a Vx2 rabbit tumor model. We hypothesized that longer duration of hyperthermia would increase Dox concentration in heated tumors without increasing systemic exposure. Temporally and spatially accurate controlled hyperthermia was achieved using a clinical MR-HIFU system for the prescribed heating durations. Forty-minutes of heating resulted in a nearly 6-fold increase in doxorubicin concentration in heated vs unheated tumors in the same animals. Therapeutic ratio, defined as the ratio of Dox delivered into the heated tumor vs the heart, increased from 1.9-fold with 10 minutes heating to 4.4-fold with 40 minutes heating. MR-HIFU can be used to guide, deliver and monitor mild hyperthermia of a Vx2 tumor model in a rabbit model, and an increased duration of heating leads to higher Dox deposition from LTSL-Dox in a target tumor without a concomitant increase in systemic exposure. Results from this preclinical study can be used to help establish clinical treatment protocols for hyperthermia mediated drug delivery.",
keywords = "mild hyperthermia, MR-guided high intensity focused ultrasound, Targeted drug delivery, therapeutic ratio, thermosensitive liposomal doxorubicin",
author = "Chenchen Bing and Pratik Patel and Staruch, {Robert M.} and Sumbul Shaikh and Joris Nofiele and {Wodzak Staruch}, Michelle and Debra Szczepanski and Williams, {Noelle S.} and Laetsch, {Theodore W} and Rajiv Chopra",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/02656736.2018.1550815",
language = "English (US)",
journal = "International Journal of Hyperthermia",
issn = "0265-6736",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin

AU - Bing, Chenchen

AU - Patel, Pratik

AU - Staruch, Robert M.

AU - Shaikh, Sumbul

AU - Nofiele, Joris

AU - Wodzak Staruch, Michelle

AU - Szczepanski, Debra

AU - Williams, Noelle S.

AU - Laetsch, Theodore W

AU - Chopra, Rajiv

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Thermosensitive liposomal doxorubicin (LTSL-Dox) combined with mild hyperthermia enhances the localized delivery of doxorubicin (Dox) within a heated region. The optimal heating duration and the impact of extended heating on systemic drug distribution are unknown. Here we evaluated local and systemic Dox delivery with two different mild hyperthermia durations (42 °C for 10 or 40 minutes) in a Vx2 rabbit tumor model. We hypothesized that longer duration of hyperthermia would increase Dox concentration in heated tumors without increasing systemic exposure. Temporally and spatially accurate controlled hyperthermia was achieved using a clinical MR-HIFU system for the prescribed heating durations. Forty-minutes of heating resulted in a nearly 6-fold increase in doxorubicin concentration in heated vs unheated tumors in the same animals. Therapeutic ratio, defined as the ratio of Dox delivered into the heated tumor vs the heart, increased from 1.9-fold with 10 minutes heating to 4.4-fold with 40 minutes heating. MR-HIFU can be used to guide, deliver and monitor mild hyperthermia of a Vx2 tumor model in a rabbit model, and an increased duration of heating leads to higher Dox deposition from LTSL-Dox in a target tumor without a concomitant increase in systemic exposure. Results from this preclinical study can be used to help establish clinical treatment protocols for hyperthermia mediated drug delivery.

AB - Thermosensitive liposomal doxorubicin (LTSL-Dox) combined with mild hyperthermia enhances the localized delivery of doxorubicin (Dox) within a heated region. The optimal heating duration and the impact of extended heating on systemic drug distribution are unknown. Here we evaluated local and systemic Dox delivery with two different mild hyperthermia durations (42 °C for 10 or 40 minutes) in a Vx2 rabbit tumor model. We hypothesized that longer duration of hyperthermia would increase Dox concentration in heated tumors without increasing systemic exposure. Temporally and spatially accurate controlled hyperthermia was achieved using a clinical MR-HIFU system for the prescribed heating durations. Forty-minutes of heating resulted in a nearly 6-fold increase in doxorubicin concentration in heated vs unheated tumors in the same animals. Therapeutic ratio, defined as the ratio of Dox delivered into the heated tumor vs the heart, increased from 1.9-fold with 10 minutes heating to 4.4-fold with 40 minutes heating. MR-HIFU can be used to guide, deliver and monitor mild hyperthermia of a Vx2 tumor model in a rabbit model, and an increased duration of heating leads to higher Dox deposition from LTSL-Dox in a target tumor without a concomitant increase in systemic exposure. Results from this preclinical study can be used to help establish clinical treatment protocols for hyperthermia mediated drug delivery.

KW - mild hyperthermia

KW - MR-guided high intensity focused ultrasound

KW - Targeted drug delivery

KW - therapeutic ratio

KW - thermosensitive liposomal doxorubicin

UR - http://www.scopus.com/inward/record.url?scp=85058363563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058363563&partnerID=8YFLogxK

U2 - 10.1080/02656736.2018.1550815

DO - 10.1080/02656736.2018.1550815

M3 - Article

C2 - 30541350

AN - SCOPUS:85058363563

JO - International Journal of Hyperthermia

JF - International Journal of Hyperthermia

SN - 0265-6736

ER -